Literature DB >> 20549575

Continuous renal replacement therapies: a brief primer for the neurointensivist.

Pritesh Patel1, Veena Nandwani, Paul J McCarthy, Steven A Conrad, L Keith Scott.   

Abstract

Continuous renal replacement therapy (CRRT) is a renal replacement modality that is often used in the ICU setting, including the neuro-ICU. This form of renal replacement therapy has been used classically for acute renal failure in patients with hemodynamic compromise, but is gaining acceptance as a method to control vascular and extra-vascular volume and mediate cytokines in non-renal diseases. Although these uses are briefly discussed, this review concentrates on the different forms of continuous renal replacement, mainly focusing on the technology of convective versus diffusive modalities and briefly on filter technology. There is also discussion on the various anticoagulation regimes used in CRRT including data on performing CRRT without anticoagulation. This review is not meant to be a discussion on the pros and cons of CRRT versus intermittent dialysis, but rather a primer on the technology of CRRT and how this therapy may affect general care of the ICU patient.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549575     DOI: 10.1007/s12028-010-9386-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  65 in total

Review 1.  Maintaining the CRRT circuit: non-anticoagulant alternatives.

Authors:  Hugh Davies; Gavin Leslie
Journal:  Aust Crit Care       Date:  2006-11       Impact factor: 2.737

2.  Continuous renal replacement therapy for liver disease.

Authors:  Andrew Davenport
Journal:  Hemodial Int       Date:  2003-10-01       Impact factor: 1.812

Review 3.  Drug dosing in acute renal failure: the role of renal replacement therapy in altering drug pharmacokinetics.

Authors:  R A Subach; M A Marx
Journal:  Adv Ren Replace Ther       Date:  1998-04

4.  Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.

Authors:  R Palsson; J L Niles
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

5.  Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates.

Authors:  S Brunet; M Leblanc; D Geadah; D Parent; S Courteau; J Cardinal
Journal:  Am J Kidney Dis       Date:  1999-09       Impact factor: 8.860

Review 6.  Continuous renal replacement therapies: an update.

Authors:  M Manns; M H Sigler; B P Teehan
Journal:  Am J Kidney Dis       Date:  1998-08       Impact factor: 8.860

7.  Predictors of prolonged mechanical ventilation in a cohort of 5123 cardiac surgical patients.

Authors:  Francesca Cislaghi; Anna Maria Condemi; Alberto Corona
Journal:  Eur J Anaesthesiol       Date:  2009-05       Impact factor: 4.330

8.  Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators.

Authors:  Shigehiko Uchino; Rinaldo Bellomo; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Heleen Oudemans-van Straaten; Claudio Ronco; John A Kellum
Journal:  Intensive Care Med       Date:  2007-06-27       Impact factor: 17.440

9.  Epidemiology of acute renal failure in ICUs: a multi-center prospective study.

Authors:  Emilios Andrikos; Paraskevi Tseke; Olga Balafa; Dinna N Cruz; Afrodite Tsinta; Marianthi Androulaki; Michael Pappas; Claudio Ronco
Journal:  Blood Purif       Date:  2009-08-14       Impact factor: 2.614

Review 10.  Clinical review: Patency of the circuit in continuous renal replacement therapy.

Authors:  Michael Joannidis; Heleen M Oudemans-van Straaten
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  5 in total

1.  Pearls & Oysters: the effects of renal replacement therapy on cerebral autoregulation.

Authors:  S-B Ko; H A Choi; E Gilmore; J M Schmidt; J Claassen; K Lee; S A Mayer; N Badjatia
Journal:  Neurology       Date:  2012-02-07       Impact factor: 9.910

2.  Blood Glutamate Reducing Effect of Hemofiltration in Critically Ill Patients.

Authors:  Evgeni Brotfain; Ruslan Kutz; Julia Grinshpun; Benjamin F Gruenbaum; Shaun E Gruenbaum; Amit Frenkel; Agzam Zhumadilov; Vladimir Zeldetz; Yoav Bichovsky; Matthew Boyko; Moti Klein; Alexander Zlotnik
Journal:  Neurotox Res       Date:  2017-08-23       Impact factor: 3.911

Review 3.  Extracorporeal methods of blood glutamate scavenging: a novel therapeutic modality.

Authors:  Agzam Zhumadilov; Matthew Boyko; Shaun E Gruenbaum; Evgeny Brotfain; Federico Bilotta; Alexander Zlotnik
Journal:  Expert Rev Neurother       Date:  2015-04-12       Impact factor: 4.618

Review 4.  Acute Kidney Injury at the Neurocritical Care Unit.

Authors:  Gonzalo Ramírez-Guerrero; Romyna Baghetti-Hernández; Claudio Ronco
Journal:  Neurocrit Care       Date:  2021-09-13       Impact factor: 3.210

5.  Rapid unexpected brain herniation in association with renal replacement therapy in acute brain injury: caution in the neurocritical care unit.

Authors:  Marcey Osgood; Rebecca Compton; Raphael Carandang; Wiley Hall; Glenn Kershaw; Susanne Muehlschlegel
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.